These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Modulating effects of WT1 on interferon-β-vitamin D association in MS. Lin R; Taylor BV; Charlesworth J; van der Mei I; Blizzard L; Stewart N; Ponsonby AL; Dwyer T; Pittas F; Simpson S Acta Neurol Scand; 2015 Apr; 131(4):231-9. PubMed ID: 25312909 [TBL] [Abstract][Full Text] [Related]
14. HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis. Mazdeh M; Taheri M; Sayad A; Bahram S; Omrani MD; Movafagh A; Inoko H; Akbari MT; Noroozi R; Hajilooi M; Solgi G Pharmacogenomics; 2016 Apr; 17(5):489-98. PubMed ID: 27020477 [TBL] [Abstract][Full Text] [Related]
16. TRAILR1 (rs20576) and GRIA3 (rs12557782) are not associated with interferon-β response in multiple sclerosis patients. Jazireian P; Sasani ST; Assarzadegan F; Azimian M Mol Biol Rep; 2020 Dec; 47(12):9659-9665. PubMed ID: 33269432 [TBL] [Abstract][Full Text] [Related]
17. Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients. Río J; Rovira A; Tintoré M; Huerga E; Nos C; Tellez N; Tur C; Comabella M; Montalban X Mult Scler; 2008 May; 14(4):479-84. PubMed ID: 18562504 [TBL] [Abstract][Full Text] [Related]
18. New natural history of interferon-beta-treated relapsing multiple sclerosis. Trojano M; Pellegrini F; Fuiani A; Paolicelli D; Zipoli V; Zimatore GB; Di Monte E; Portaccio E; Lepore V; Livrea P; Amato MP Ann Neurol; 2007 Apr; 61(4):300-6. PubMed ID: 17444502 [TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type. Nikfar S; Rahimi R; Abdollahi M Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482 [TBL] [Abstract][Full Text] [Related]
20. Inverse Relation between MxA Gene Expression and Age in Multiple Sclerosis Patients Reveals a Gender Difference in Response to Interferon Therapy. Taheri M; Mirinezhad M; Omrani MD; Sajjadi E; Inoko H; Sayad A Iran J Allergy Asthma Immunol; 2017 Feb; 16(1):21-27. PubMed ID: 28417621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]